Toggle Dropdown
Groups
Announcements
Projects
News & Events
Welcome guest
Log in
Friends
Loading
Loading...
https://www.cnbc.com/2025/12/18/eli-lilly-obesity-pill-maintains-weight-loss-after-wegovy-zepbound-.html
0
0
Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound - CNBC
12/18/25 at 11:45am
Organization
CNBC
Author
Annika Kim Constantino
39 words
0
Comments
Eli Lilly also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for obesity.
Obesity
Drugs & Medications
Weight Loss
Business & Industrial
Pharmaceuticals & Biotech
Health News
Company News
You are the first to view
Create an account
or
login
to join the discussion
Modal title
...
Profile
Loading profile
Loading...